We hereby announce a change in Chief Executive Officer (CEO) of FIMECS, Inc., effective March 1, 2026.
Details
| Name | New Position | Current Position |
| Kanae Gamo | Chief Executive Officer | Chief Scientific Officer |
| Katsuhiro Uto | Director (also Director of RaQualia Pharma Inc.) |
Representative Director & CEO (also Director of RaQualia Pharma Inc.) |
Reason for Change
The RaQualia Group prioritizes achieving the business plan announced on February 13, 2026, aiming to enhance growth potential, corporate value, and shareholder value. This change is intended to enable the optimal utilization of management resources across the group, allowing the company to respond swiftly and appropriately to changes in the business environment, enhance business competitiveness, and accelerate the achievement of its goals.
# # #
FIMECS, Inc. Media and Investor Contact:
FIMECS, Inc.
26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012, Japan
Tel: +81-466-96-0261
E-mail: info@fimecs.com